Carcinoma: all 6,718 studies
Page 47 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant TACE to Reduce the HCC Recurrence After ResectionCompletedNCT02788526Phase 3
- DC1s-CTL Cellular Therapy for Renal Cell CarcinomaStatus unknownNCT02787915Phase 1/2
- Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02786641Phase 3
- Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept StudyCompletedNCT02786459Not applicable
- Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
- An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung CancerNo longer availableNCT02784158
- Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive CancerCompletedNCT02784028Not applicable
- Prospective Post Y90 Liver HypertrophyStatus unknownNCT02783261
- Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World ConditionsCompletedNCT02781389
- Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02778191
- Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and NeckCompletedNCT02776137Phase 2
- Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma PatientsCompletedNCT02776124Phase 2
- Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell CarcinomaCompletedNCT02775812Phase 1
- A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT02775370Phase 2
- Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell CarcinomaTerminatedNCT02775006Phase 3
- A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.Status unknownNCT02774200Phase 2
- B-mode Ultrasound Imaging in Detecting Early Liver CancerCompletedNCT02774161Not applicable
- Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-IodineCompletedNCT02773667
- A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment FailureStatus unknownNCT02772029Phase 1/2
- sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
- Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After ResectionStatus unknownNCT02767375Phase 2/3
- A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine CervixCompletedNCT02765919Phase 3
- Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO TrialStatus unknownNCT02765503Not applicable
- Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck CancerCompletedNCT02764593Phase 1
- Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell CarcinomaCompletedNCT02762006Phase 1
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)Status unknownNCT02759601Phase 1/2
- Radiomics of Hepatocellular CarcinomaStatus unknownNCT02757846
- CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTerminatedNCT02757391Phase 1
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the LungStatus unknownNCT02755675Phase 2
- Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular CarcinomaStatus unknownNCT02755311Phase 3
- Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant ChemotherapyStatus unknownNCT02753140Phase 2
- Intraoperative Margin Assessment During Mohs SurgeryWithdrawnNCT02750033
- Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized StudyStatus unknownNCT02748707Phase 2
- Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular CarcinomaTerminatedNCT02748304Not applicable
- DEB-TACE for Hepatocellular CarcinomaTerminatedNCT02748161Not applicable
- Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma PatientsStatus unknownNCT02740426Phase 2
- Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell CarcinomaStatus unknownNCT02739204Phase 2
- Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder CarcinomaCompletedNCT02736266Phase 2
- Topical Itraconazole in Treating Patients With Basal Cell CancerCompletedNCT02735356Early Phase 1
- Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02735317Phase 2
- Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT02733809Phase 4
- Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell CarcinomaCompletedNCT02732665
- Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell CarcinomaCompletedNCT02732652
- Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)Active, not recruitingNCT02730923Phase 1/2
- Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and CholangiocarcinomaCompletedNCT02730611
- Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular CarcinomaStatus unknownNCT02729506Phase 4
- Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02729324Phase 2
- First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid TumorsCompletedNCT02729298Phase 1
- Standard Treatments of Very-early Stage Hepatocellular CarcinomaCompletedNCT02728193Not applicable
- A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma PatientsStatus unknownNCT02727309Phase 1/2
- By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative TherapyStatus unknownNCT02725996Phase 2
- Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor ThrombusCompletedNCT02724475Not applicable
- Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular CarcinomaCompletedNCT02724436Not applicable
- Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1CompletedNCT02724358Not applicable
- Postoperative Adjuvant TACE Treatment in CK18 Positive PatientsCompletedNCT02724345
- Targeted Internal Radiation Therapy in Advanced HCC Patients.CompletedNCT02724267Not applicable
- CAR-T Cell Immunotherapy for HCC Targeting GPC3WithdrawnNCT02723942Phase 1/2
- Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the BladderWithdrawnNCT02723838Phase 1
- A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver TransplantationStatus unknownNCT02719782Phase 1
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder CancerWithdrawnNCT02718742Phase 2
- Investigation of Desmoplastic Squamous Cell CarcinomaStatus unknownNCT02717936Not applicable
- Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02716766Phase 2
- Changes in Body Composition After EPA Supplementation in Head and Neck PatientsCompletedNCT02715596Phase 3
- A Study of GPC3 Redirected Autologous T Cells for Advanced HCCStatus unknownNCT02715362Phase 1/2
- Circulating Tumor DNA in Patients at High Risk for Lung CancerTerminatedNCT02715102
- Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast CancerTerminatedNCT02708511Phase 1
- Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCCCompletedNCT02707588Phase 2
- Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular CarcinomaCompletedNCT02705118Not applicable
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Compassionate Use of MitoGel in Upper Tract Urothelial CarcinomaNo longer availableNCT02701023
- The Cxbladder Monitoring StudyCompletedNCT02700659
- Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic FactorsCompletedNCT02700568Phase 2
- Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell CancerWithdrawnNCT02699723Early Phase 1
- Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal CarcinomaTerminatedNCT02698111Phase 1/2
- Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary OriginStatus unknownNCT02695459Phase 2
- The PROMISE Study: Duavee in Women With DCISCompletedNCT02694809Phase 2
- Post-radiation Hypothyroidism After IMRT for Nasopharyngeal CarcinomaCompletedNCT02689609
- Study to Assess Various Sunitinib Schedules in Renal Cell CarcinomaStatus unknownNCT02689167Phase 2
- Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic OriginActive, not recruitingNCT02687958Phase 2
- A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver TransplantationCompletedNCT02686372Phase 1
- Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCCWithdrawnNCT02686008Phase 1
- MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
- Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular InvasionStatus unknownNCT02678806Not applicable
- Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT02677597Phase 3
- NCCN Renal Cell RegistryCompletedNCT02677337Not applicable
- Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)CompletedNCT02674009
- Metformin Plus Sorafenib for Advanced HCCStatus unknownNCT02672488Phase 2
- Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast CancerCompletedNCT02672475Phase 1
- New Strategies Against Cutaneous Squamous Cell CarcinomaCompletedNCT02672254
- Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing CryosurgeryWithdrawnNCT02671552Early Phase 1
- Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian OriginWithdrawnNCT02667925Not applicable
- Optical Imaging for Preoperative Delineation of Nonmelanoma Skin CancersStatus unknownNCT02666833
- Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell CarcinomaCompletedNCT02666534Phase 1
- Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasStatus unknownNCT02665702Phase 2
- A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionCompletedNCT02665039Phase 2
- Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous CellStatus unknownNCT02663583
- Preoperative MPDL3280A in Transitional Cell Carcinoma of the BladderCompletedNCT02662309Phase 2
- DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.Status unknownNCT02661152Phase 3